Comparative efficacy and safety of two insulin aspart formulations (Rapilin and NovoRapid) when combined with metformin, for patients with diabetes mellitus: a multicenter, randomized, open-label, controlled clinical trial.
Current medical research and opinion(2022)
Abstract
ChiCTR20003129041.
MoreTranslated text
Key words
Clinical trial,NovoRapid,Rapilin,diabetes mellitus,efficacy,insulin aspart
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined